- Home
- CRVO vs SRL Comparison
CRVO vs SRL Comparison
Compare CRVO & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- SRL
- Stock Information
- Founded
- CRVO 2001
- SRL 2017
- Country
- CRVO United States
- SRL China
- Employees
- CRVO N/A
- SRL N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- SRL Professional Services
- Sector
- CRVO Health Care
- SRL Consumer Discretionary
- Exchange
- CRVO Nasdaq
- SRL Nasdaq
- Market Cap
- CRVO 67.4M
- SRL 79.0M
- IPO Year
- CRVO N/A
- SRL N/A
- Fundamental
- Price
- CRVO $10.51
- SRL $5.45
- Analyst Decision
- CRVO Strong Buy
- SRL
- Analyst Count
- CRVO 6
- SRL 0
- Target Price
- CRVO $20.80
- SRL N/A
- AVG Volume (30 Days)
- CRVO 119.1K
- SRL 3.1K
- Earning Date
- CRVO 08-08-2025
- SRL 04-30-2025
- Dividend Yield
- CRVO N/A
- SRL 19.08%
- EPS Growth
- CRVO N/A
- SRL N/A
- EPS
- CRVO N/A
- SRL N/A
- Revenue
- CRVO $7,776,968.00
- SRL $24,535,042.00
- Revenue This Year
- CRVO N/A
- SRL N/A
- Revenue Next Year
- CRVO N/A
- SRL N/A
- P/E Ratio
- CRVO N/A
- SRL N/A
- Revenue Growth
- CRVO N/A
- SRL N/A
- 52 Week Low
- CRVO $1.80
- SRL $5.13
- 52 Week High
- CRVO $20.63
- SRL $9.99
- Technical
- Relative Strength Index (RSI)
- CRVO 63.06
- SRL 47.56
- Support Level
- CRVO $9.61
- SRL $5.16
- Resistance Level
- CRVO $10.89
- SRL $5.47
- Average True Range (ATR)
- CRVO 0.67
- SRL 0.22
- MACD
- CRVO 0.04
- SRL 0.04
- Stochastic Oscillator
- CRVO 70.28
- SRL 41.56
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.